updated 10/20/2004 6:21:52 PM ET 2004-10-20T22:21:52

Strong sales of key products drove third quarter earnings at Pfizer Inc. up 50 percent, the world's largest drug company said Wednesday.

Pfizer earned $3.34 billion, or 45 cents a share, for the July-September period, up from $2.24 billion, or 29 cents a share, in the year ago period.

Excluding charges such as the acquisition of Pharmacia and income from discontinued operations, Pfizer earnings rose 13 percent to $4.16 billion, or 55 cents per share. That beat by one cent a share the consensus estimate of analysts surveyed by Financial First Call.

Third quarter revenue rose 4 percent to $12.83 billion from $12.35 billion. Sales of cholesterol drug Lipitor rose 11 percent to $2.7 billion while revenue from pain reliever Celebrex grew 14 percent to $797 million.

However, impotency pill Viagra sales dropped 15 percent to $403 million because of two new competitors.

For the first nine months of the year, Pfizer earned $8.54 billion, or $1.12 a share, up from $3.31 billion, or 46 cents a share, a year earlier.

Nine-month revenue rose 22 percent to $37.59 billion from $30.75 billion a year ago.

© 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 4.71%
$30K home equity loan FICO 5.26%
$75K home equity loan FICO 4.70%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.42%
13.42%
Cash Back Cards 17.94%
17.94%
Rewards Cards 17.14%
17.14%
Source: Bankrate.com